Scientific and corporate news
A review: therapeutic potential of adipose- derived stem cells in cutaneous wound healing and regenaration
As the most important barrier for the human body, the skin often suffers from acute and chronic injuries, especially refractory wounds, which seriously affect the
Human mesenchymal stem cell treatment
of premature ovarian failure: new
challenges and opportunities
Premature ovarian failure (POF) is one of the common disorders found in women leading to 1% female infertility.
Safety and efficacy of intracoronary human umbilical cord-derived mesenchymal stem cell treatment for very old patients with coronary chronic total occlusion
This study aimed to investigate the safety and feasibility of intracoronary injection of human umbilical cord mesenchymal stem cell to the very old patients with coronary chronic total occlusion 15 consecutive patients received mesenchymal stem cells from human umbilical cord in epicardial coronary artery supplying collateral circulation.
Human mesenchymal stem cell treatment
of premature ovarian failure: new
challenges and opportunities
Premature ovarian failure (POF) is a common endocrine disease causing female infertility. It is characterized by high gonadotropin expression [follicle-stimulating hormone (FSH) ≥ 40 mIU/mL], low estradiol (E2) expression, and follicular dysplasia in women aged less than 40 years [1].
Autologous Cord Blood Infusions Are Safe and
Feasible in Young Children with Autism Spectrum
Disorder: Results of a Single-Center Phase I
Open-Label Trial
Despite advances in early diagnosis and behavioral therapies, more effective treatments for children with autism spectrum disorder (ASD) are needed
Mesenchymal Stem Cells as a Bio Organ for
Treatment of Female Infertility
Female infertility is a global medical condition that can be caused by various disorders of the reproductive system, including premature ovarian failure (POF), polycystic ovary